Valuation results in 3Q13 showed a noticeable increase over 2Q13, including the greatest difference between up and down rounds in over six years. The software industry was especially strong, not only valuation-wise, but also in the number of deals.
Bio Tech
Google-backed 23andMe Inc's row with regulators leads to strict oversight of personal gene tests- report
The row that occurred between 23andMe Inc and the Food and Drug Administration has led to stricter oversight of the genetic testing industry, according to a Bloomberg report.
US-based Monsanto, Novozymes of Denmark form long-term microbial alliance
Monsanto Company and Novozymes A/S formed a strategic cooperation called "The BioAg Alliance" in order to capitalize each other's capabilities in microbial technologies and commercial markets.
Report gives top 30 venture capital firms of 2013 for biotech and pharmaceutical firms
The Genetic Engineering & Biotechnology News or GEN website revealed its top 30 list of venture capital firms for biotechnology and pharmaceutical companies. This report summarizes those who have made it to the top 10.
Cordlife increases stake in Malaysia's StemLife
Singapore-listed umbilical cord blood and tissue banking service provider Cordlife Group Limited announces its acquisition of an additional 11.89% stake in Malaysia-based StemLife for a total of SGD7 million.
Latest News
LDR Holdings Chief Executive Officer Christophe Lavigne talked to Xconomy 30 days after it had launched an initial public offering, and said money raised from its IPO will help the company expand its presence in the US.
The following bids, mergers, acquisitions and disposals were reported on Monday including Greece banking, Fiat, BOFA, Mechel, Saputo, RBS, Lohmann, Carlyle Group, Monte dei Paschi di Siena, Kuwait Airways, Dubai Holding, SunEdison, Blackstone, Greece National Bank, IMG Worldwide, KKR, Babcock, AMR, Orrick, BAC and Fisker Automotive.
A consortium of venture capitalists had helped Editas Medicine raised USD43 million in Series A financing to create medicine designed to eradicate gene abnormalities.
A survey taken by professional services company Ernst & Young has shown that India has toppled China from the top spot as the world's most attractive destination for investments.
Sitari Pharmaceuticals, a San Diego, CA-based developer of multiple disease indication treatments with a focus on celiac diseases, raised USD 10 million in Series A funding. The fund would be used to continue supporting research and development of novel treatments for celiac diseases.
Ikaria Inc is being fought over by BC Partners Ltd, Onex Corp and American Securities LLC, of which the bidding war could fetch up to USD 2 billion for the former, according to sources who were familiar with the matter.
US-based pharmaceutical company Moderna Therapeutics announced its completion of a new funding round worth USD110 million for the development of its messenger ribonucleic (RNA) Therapeutics.
A report from the UN Food and Agriculture Organization revealed that political will and farmer involvement are crucial for biotech research and innovation to succeed in reducing poverty in developing countries.
Shares in Swiss biotech company Actelion rose on Thursday after broker Citi said in a research note British pharma group AstraZeneca might be interested in buying it.
